Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-20-000816
Filing Date
2020-01-17
Accepted
2020-01-17 17:15:07
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 gnpx20200110_424b5.htm 424B5 522420
2 g1.jpg GRAPHIC 51744
3 gnpx20190906_s3img001.jpg GRAPHIC 5821
4 gnpx20190906_s3img002.jpg GRAPHIC 16268
5 gnpx20191120_424b5img001.jpg GRAPHIC 5649
  Complete submission text file 0001437749-20-000816.txt   633391
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233774 | Film No.: 20534359
SIC: 2834 Pharmaceutical Preparations